APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable HIV Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Injectable HIV Medication Market Analysis and Forecast 2026-2032

29 December 2025199 pages

Choose your research edition.

Industry ResearchInjectable HIV Medication Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable HIV Medication Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Injectable HIV Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable HIV Medication Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable HIV Medication Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Injectable HIV Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Injectable HIV Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Injectable HIV Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Injectable HIV Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Injectable HIV Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Injectable HIV Medication include Theratechnologies, ViiV Healthcare, Gilead Sciences and Janssen Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Injectable HIV Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Injectable HIV Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Injectable HIV Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Injectable HIV Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Injectable HIV Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Injectable HIV Medication sales, projected growth trends, production technology, application and end-user industry.

Injectable HIV Medication Segment by Company

Theratechnologies

ViiV Healthcare

Gilead Sciences

Janssen Pharmaceuticals

Injectable HIV Medication Segment by Type

Integrase Inhibitors

Capsid Inhibitors

NNRTIs

Monoclonal Antibodies

Other

Injectable HIV Medication Segment by Application

Pre-Exposure Prophylaxis

HIV Treatment

Injectable HIV Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable HIV Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable HIV Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable HIV Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Injectable HIV Medication in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Injectable HIV Medication manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable HIV Medication sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Injectable HIV Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Integrase Inhibitors Major Manufacturers Table 3. Capsid Inhibitors Major Manufacturers Table 4. NNRTIs Major Manufacturers Table 5. Monoclonal Antibodies Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Injectable HIV Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pre-Exposure Prophylaxis Major Manufacturers Table 9. HIV Treatment Major Manufacturers Table 10. Injectable HIV Medication Industry Trends Table 11. Injectable HIV Medication Industry Drivers Table 12. Injectable HIV Medication Industry Opportunities and Challenges Table 13. Injectable HIV Medication Industry Restraints Table 14. Global Injectable HIV Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Injectable HIV Medication Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Injectable HIV Medication Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Injectable HIV Medication Revenue Market Share by Region (2021-2026) Table 18. Global Injectable HIV Medication Revenue Market Share by Region (2027-2032) Table 19. Global Injectable HIV Medication Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Injectable HIV Medication Sales by Region (2021-2026) & (K Units) Table 21. Global Injectable HIV Medication Sales by Region (2027-2032) & (K Units) Table 22. Global Injectable HIV Medication Sales Market Share by Region (2021-2026) Table 23. Global Injectable HIV Medication Sales Market Share by Region (2027-2032) Table 24. Global Injectable HIV Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Injectable HIV Medication Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Injectable HIV Medication Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Injectable HIV Medication Sales Market Share by Manufacturers (2021-2026) Table 28. Global Injectable HIV Medication Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Injectable HIV Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Injectable HIV Medication Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Injectable HIV Medication Manufacturers, Product Type & Application Table 32. Global Injectable HIV Medication Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Injectable HIV Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Injectable HIV Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Injectable HIV Medication Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Injectable HIV Medication Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Injectable HIV Medication Revenue Market Share by Type (2021-2026) Table 39. Global Injectable HIV Medication Revenue Market Share by Type (2027-2032) Table 40. Global Injectable HIV Medication Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Injectable HIV Medication Sales by Type (2021-2026) & (K Units) Table 42. Global Injectable HIV Medication Sales by Type (2027-2032) & (K Units) Table 43. Global Injectable HIV Medication Sales Market Share by Type (2021-2026) Table 44. Global Injectable HIV Medication Sales Market Share by Type (2027-2032) Table 45. Global Injectable HIV Medication Price by Type (2021-2026) & (US$/Unit) Table 46. Global Injectable HIV Medication Price by Type (2027-2032) & (US$/Unit) Table 47. Global Injectable HIV Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Injectable HIV Medication Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Injectable HIV Medication Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Injectable HIV Medication Revenue Market Share by Application (2021-2026) Table 51. Global Injectable HIV Medication Revenue Market Share by Application (2027-2032) Table 52. Global Injectable HIV Medication Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Injectable HIV Medication Sales by Application (2021-2026) & (K Units) Table 54. Global Injectable HIV Medication Sales by Application (2027-2032) & (K Units) Table 55. Global Injectable HIV Medication Sales Market Share by Application (2021-2026) Table 56. Global Injectable HIV Medication Sales Market Share by Application (2027-2032) Table 57. Global Injectable HIV Medication Price by Application (2021-2026) & (US$/Unit) Table 58. Global Injectable HIV Medication Price by Application (2027-2032) & (US$/Unit) Table 59. Theratechnologies Company Information Table 60. Theratechnologies Business Overview Table 61. Theratechnologies Injectable HIV Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Theratechnologies Injectable HIV Medication Product Portfolio Table 63. Theratechnologies Recent Development Table 64. ViiV Healthcare Company Information Table 65. ViiV Healthcare Business Overview Table 66. ViiV Healthcare Injectable HIV Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. ViiV Healthcare Injectable HIV Medication Product Portfolio Table 68. ViiV Healthcare Recent Development Table 69. Gilead Sciences Company Information Table 70. Gilead Sciences Business Overview Table 71. Gilead Sciences Injectable HIV Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Gilead Sciences Injectable HIV Medication Product Portfolio Table 73. Gilead Sciences Recent Development Table 74. Janssen Pharmaceuticals Company Information Table 75. Janssen Pharmaceuticals Business Overview Table 76. Janssen Pharmaceuticals Injectable HIV Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Janssen Pharmaceuticals Injectable HIV Medication Product Portfolio Table 78. Janssen Pharmaceuticals Recent Development Table 79. North America Injectable HIV Medication Revenue by Type (2021-2026) & (US$ Million) Table 80. North America Injectable HIV Medication Revenue by Type (2027-2032) & (US$ Million) Table 81. North America Injectable HIV Medication Sales by Type (2021-2026) & (K Units) Table 82. North America Injectable HIV Medication Sales by Type (2027-2032) & (K Units) Table 83. North America Injectable HIV Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 84. North America Injectable HIV Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 85. North America Injectable HIV Medication Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Injectable HIV Medication Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Injectable HIV Medication Sales by Application (2021-2026) & (K Units) Table 88. North America Injectable HIV Medication Sales by Application (2027-2032) & (K Units) Table 89. North America Injectable HIV Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 90. North America Injectable HIV Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 91. North America Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Injectable HIV Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 93. North America Injectable HIV Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 94. North America Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 95. North America Injectable HIV Medication Sales by Country (2021-2026) & (K Units) Table 96. North America Injectable HIV Medication Sales by Country (2027-2032) & (K Units) Table 97. North America Injectable HIV Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 98. North America Injectable HIV Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 99. United States Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 100. Canada Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 101. Mexico Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 102. Europe Injectable HIV Medication Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Injectable HIV Medication Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Injectable HIV Medication Sales by Type (2021-2026) & (K Units) Table 105. Europe Injectable HIV Medication Sales by Type (2027-2032) & (K Units) Table 106. Europe Injectable HIV Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 107. Europe Injectable HIV Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 108. Europe Injectable HIV Medication Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Injectable HIV Medication Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Injectable HIV Medication Sales by Application (2021-2026) & (K Units) Table 111. Europe Injectable HIV Medication Sales by Application (2027-2032) & (K Units) Table 112. Europe Injectable HIV Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 113. Europe Injectable HIV Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 114. Europe Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Injectable HIV Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe Injectable HIV Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. Europe Injectable HIV Medication Sales by Country (2021-2026) & (K Units) Table 119. Europe Injectable HIV Medication Sales by Country (2027-2032) & (K Units) Table 120. Europe Injectable HIV Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 121. Europe Injectable HIV Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 122. Germany Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 123. France Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 124. U.K. Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 125. Italy Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 126. Russia Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 127. Spain Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 128. Netherlands Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 129. Switzerland Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 130. Sweden Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 131. Poland Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 132. China Injectable HIV Medication Revenue by Type (2021-2026) & (US$ Million) Table 133. China Injectable HIV Medication Revenue by Type (2027-2032) & (US$ Million) Table 134. China Injectable HIV Medication Sales by Type (2021-2026) & (K Units) Table 135. China Injectable HIV Medication Sales by Type (2027-2032) & (K Units) Table 136. China Injectable HIV Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 137. China Injectable HIV Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 138. China Injectable HIV Medication Revenue by Application (2021-2026) & (US$ Million) Table 139. China Injectable HIV Medication Revenue by Application (2027-2032) & (US$ Million) Table 140. China Injectable HIV Medication Sales by Application (2021-2026) & (K Units) Table 141. China Injectable HIV Medication Sales by Application (2027-2032) & (K Units) Table 142. China Injectable HIV Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 143. China Injectable HIV Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Injectable HIV Medication Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Injectable HIV Medication Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Injectable HIV Medication Sales by Type (2021-2026) & (K Units) Table 147. Asia Injectable HIV Medication Sales by Type (2027-2032) & (K Units) Table 148. Asia Injectable HIV Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Asia Injectable HIV Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Asia Injectable HIV Medication Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Injectable HIV Medication Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Injectable HIV Medication Sales by Application (2021-2026) & (K Units) Table 153. Asia Injectable HIV Medication Sales by Application (2027-2032) & (K Units) Table 154. Asia Injectable HIV Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Asia Injectable HIV Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Injectable HIV Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Asia Injectable HIV Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Asia Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Asia Injectable HIV Medication Sales by Country (2021-2026) & (K Units) Table 161. Asia Injectable HIV Medication Sales by Country (2027-2032) & (K Units) Table 162. Asia Injectable HIV Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Asia Injectable HIV Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Japan Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 165. South Korea Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 166. India Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 167. Australia Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 168. Taiwan Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 169. Southeast Asia Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 170. SAMEA Injectable HIV Medication Revenue by Type (2021-2026) & (US$ Million) Table 171. SAMEA Injectable HIV Medication Revenue by Type (2027-2032) & (US$ Million) Table 172. SAMEA Injectable HIV Medication Sales by Type (2021-2026) & (K Units) Table 173. SAMEA Injectable HIV Medication Sales by Type (2027-2032) & (K Units) Table 174. SAMEA Injectable HIV Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 175. SAMEA Injectable HIV Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 176. SAMEA Injectable HIV Medication Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Injectable HIV Medication Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Injectable HIV Medication Sales by Application (2021-2026) & (K Units) Table 179. SAMEA Injectable HIV Medication Sales by Application (2027-2032) & (K Units) Table 180. SAMEA Injectable HIV Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 181. SAMEA Injectable HIV Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 182. SAMEA Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. SAMEA Injectable HIV Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. SAMEA Injectable HIV Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. SAMEA Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. SAMEA Injectable HIV Medication Sales by Country (2021-2026) & (K Units) Table 187. SAMEA Injectable HIV Medication Sales by Country (2027-2032) & (K Units) Table 188. SAMEA Injectable HIV Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 189. SAMEA Injectable HIV Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Brazil Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 191. Argentina Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 192. Chile Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 193. Colombia Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 194. Peru Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 195. Saudi Arabia Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 196. Israel Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 197. UAE Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 198. Turkey Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 199. Iran Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 200. Egypt Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Injectable HIV Medication Distributors List Table 204. Injectable HIV Medication Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Injectable HIV Medication Image Figure 2. Global Injectable HIV Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable HIV Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Integrase Inhibitors Image Figure 5. Capsid Inhibitors Image Figure 6. NNRTIs Image Figure 7. Monoclonal Antibodies Image Figure 8. Other Image Figure 9. Global Injectable HIV Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Injectable HIV Medication Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pre-Exposure Prophylaxis Image Figure 12. HIV Treatment Image Figure 13. Global Injectable HIV Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Injectable HIV Medication Revenue (2021-2032) & (US$ Million) Figure 15. Global Injectable HIV Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Injectable HIV Medication Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Injectable HIV Medication Revenue Market Share by Region (2021-2032) Figure 18. Global Injectable HIV Medication Sales (2021-2032) & (K Units) Figure 19. Global Injectable HIV Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Injectable HIV Medication Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Injectable HIV Medication Sales YoY (2021-2032) & (K Units) Figure 22. Europe Injectable HIV Medication Sales YoY (2021-2032) & (K Units) Figure 23. China Injectable HIV Medication Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Injectable HIV Medication Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Injectable HIV Medication Sales YoY (2021-2032) & (K Units) Figure 26. Global Injectable HIV Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Injectable HIV Medication Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Injectable HIV Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Injectable HIV Medication Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Injectable HIV Medication Revenue Market Share by Type (2021-2032) Figure 32. Global Injectable HIV Medication Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Injectable HIV Medication Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Injectable HIV Medication Sales Market Share by Type (2021-2032) Figure 35. Global Injectable HIV Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Injectable HIV Medication Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Injectable HIV Medication Revenue Market Share by Application (2021-2032) Figure 38. Global Injectable HIV Medication Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Injectable HIV Medication Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Injectable HIV Medication Sales Market Share by Application (2021-2032) Figure 41. North America Injectable HIV Medication Revenue Share by Type (2021-2032) Figure 42. North America Injectable HIV Medication Sales Share by Type (2021-2032) Figure 43. North America Injectable HIV Medication Revenue Share by Application (2021-2032) Figure 44. North America Injectable HIV Medication Sales Share by Application (2021-2032) Figure 45. North America Injectable HIV Medication Revenue Share by Country (2021-2032) Figure 46. North America Injectable HIV Medication Sales Share by Country (2021-2032) Figure 47. Europe Injectable HIV Medication Revenue Share by Type (2021-2032) Figure 48. Europe Injectable HIV Medication Sales Share by Type (2021-2032) Figure 49. Europe Injectable HIV Medication Revenue Share by Application (2021-2032) Figure 50. Europe Injectable HIV Medication Sales Share by Application (2021-2032) Figure 51. Europe Injectable HIV Medication Revenue Share by Country (2021-2032) Figure 52. Europe Injectable HIV Medication Sales Share by Country (2021-2032) Figure 53. China Injectable HIV Medication Revenue Share by Type (2021-2032) Figure 54. China Injectable HIV Medication Sales Share by Type (2021-2032) Figure 55. China Injectable HIV Medication Revenue Share by Application (2021-2032) Figure 56. China Injectable HIV Medication Sales Share by Application (2021-2032) Figure 57. Asia Injectable HIV Medication Revenue Share by Type (2021-2032) Figure 58. Asia Injectable HIV Medication Sales Share by Type (2021-2032) Figure 59. Asia Injectable HIV Medication Revenue Share by Application (2021-2032) Figure 60. Asia Injectable HIV Medication Sales Share by Application (2021-2032) Figure 61. Asia Injectable HIV Medication Revenue Share by Country (2021-2032) Figure 62. Asia Injectable HIV Medication Sales Share by Country (2021-2032) Figure 63. SAMEA Injectable HIV Medication Revenue Share by Type (2021-2032) Figure 64. SAMEA Injectable HIV Medication Sales Share by Type (2021-2032) Figure 65. SAMEA Injectable HIV Medication Revenue Share by Application (2021-2032) Figure 66. SAMEA Injectable HIV Medication Sales Share by Application (2021-2032) Figure 67. SAMEA Injectable HIV Medication Revenue Share by Country (2021-2032) Figure 68. SAMEA Injectable HIV Medication Sales Share by Country (2021-2032) Figure 69. Injectable HIV Medication Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Injectable HIV Medication Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Integrase Inhibitors
  • Capsid Inhibitors
  • NNRTIs
  • Monoclonal Antibodies
  • Other
Applications
  • Pre-Exposure Prophylaxis
  • HIV Treatment
Companies covered
  • Theratechnologies
  • ViiV Healthcare
  • Gilead Sciences
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Injectable HIV Medication Market by Type
  3. 1.2.1 Global Injectable HIV Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Integrase Inhibitors
  5. 1.2.3 Capsid Inhibitors
  6. 1.2.4 NNRTIs
  7. 1.2.5 Monoclonal Antibodies
  8. 1.2.6 Other
  9. 1.3 Injectable HIV Medication Market by Application
  10. 1.3.1 Global Injectable HIV Medication Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pre-Exposure Prophylaxis
  12. 1.3.3 HIV Treatment
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Injectable HIV Medication Market Dynamics
  1. 2.1 Injectable HIV Medication Industry Trends
  2. 2.2 Injectable HIV Medication Industry Drivers
  3. 2.3 Injectable HIV Medication Industry Opportunities and Challenges
  4. 2.4 Injectable HIV Medication Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Injectable HIV Medication Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Injectable HIV Medication Revenue by Region
  3. 3.2.1 Global Injectable HIV Medication Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Injectable HIV Medication Revenue by Region (2021-2026)
  5. 3.2.3 Global Injectable HIV Medication Revenue by Region (2027-2032)
  6. 3.2.4 Global Injectable HIV Medication Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Injectable HIV Medication Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Injectable HIV Medication Sales by Region
  9. 3.4.1 Global Injectable HIV Medication Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Injectable HIV Medication Sales by Region (2021-2026)
  11. 3.4.3 Global Injectable HIV Medication Sales by Region (2027-2032)
  12. 3.4.4 Global Injectable HIV Medication Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Injectable HIV Medication Revenue by Manufacturers
  2. 4.1.1 Global Injectable HIV Medication Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Injectable HIV Medication Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Injectable HIV Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Injectable HIV Medication Sales by Manufacturers
  6. 4.2.1 Global Injectable HIV Medication Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Injectable HIV Medication Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Injectable HIV Medication Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Injectable HIV Medication Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Injectable HIV Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Injectable HIV Medication Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Injectable HIV Medication Manufacturers, Product Type & Application
  13. 4.7 Global Injectable HIV Medication Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Injectable HIV Medication Market CR5 and HHI
  16. 4.8.2 2025 Injectable HIV Medication Tier 1, Tier 2, and Tier 3
5 Injectable HIV Medication Market by Type
  1. 5.1 Global Injectable HIV Medication Revenue by Type
  2. 5.1.1 Global Injectable HIV Medication Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Injectable HIV Medication Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Injectable HIV Medication Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Injectable HIV Medication Sales by Type
  6. 5.2.1 Global Injectable HIV Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injectable HIV Medication Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Injectable HIV Medication Sales Market Share by Type (2021-2032)
  9. 5.3 Global Injectable HIV Medication Price by Type
6 Injectable HIV Medication Market by Application
  1. 6.1 Global Injectable HIV Medication Revenue by Application
  2. 6.1.1 Global Injectable HIV Medication Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Injectable HIV Medication Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Injectable HIV Medication Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Injectable HIV Medication Sales by Application
  6. 6.2.1 Global Injectable HIV Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Injectable HIV Medication Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Injectable HIV Medication Sales Market Share by Application (2021-2032)
  9. 6.3 Global Injectable HIV Medication Price by Application
7 Company Profiles
  1. 7.1 Theratechnologies
  2. 7.1.1 Theratechnologies Company Information
  3. 7.1.2 Theratechnologies Business Overview
  4. 7.1.3 Theratechnologies Injectable HIV Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Theratechnologies Injectable HIV Medication Product Portfolio
  6. 7.1.5 Theratechnologies Recent Developments
  7. 7.2 ViiV Healthcare
  8. 7.2.1 ViiV Healthcare Company Information
  9. 7.2.2 ViiV Healthcare Business Overview
  10. 7.2.3 ViiV Healthcare Injectable HIV Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ViiV Healthcare Injectable HIV Medication Product Portfolio
  12. 7.2.5 ViiV Healthcare Recent Developments
  13. 7.3 Gilead Sciences
  14. 7.3.1 Gilead Sciences Company Information
  15. 7.3.2 Gilead Sciences Business Overview
  16. 7.3.3 Gilead Sciences Injectable HIV Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gilead Sciences Injectable HIV Medication Product Portfolio
  18. 7.3.5 Gilead Sciences Recent Developments
  19. 7.4 Janssen Pharmaceuticals
  20. 7.4.1 Janssen Pharmaceuticals Company Information
  21. 7.4.2 Janssen Pharmaceuticals Business Overview
  22. 7.4.3 Janssen Pharmaceuticals Injectable HIV Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Janssen Pharmaceuticals Injectable HIV Medication Product Portfolio
  24. 7.4.5 Janssen Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Injectable HIV Medication Market Size by Type
  2. 8.1.1 North America Injectable HIV Medication Revenue by Type (2021-2032)
  3. 8.1.2 North America Injectable HIV Medication Sales by Type (2021-2032)
  4. 8.1.3 North America Injectable HIV Medication Price by Type (2021-2032)
  5. 8.2 North America Injectable HIV Medication Market Size by Application
  6. 8.2.1 North America Injectable HIV Medication Revenue by Application (2021-2032)
  7. 8.2.2 North America Injectable HIV Medication Sales by Application (2021-2032)
  8. 8.2.3 North America Injectable HIV Medication Price by Application (2021-2032)
  9. 8.3 North America Injectable HIV Medication Market Size by Country
  10. 8.3.1 North America Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Injectable HIV Medication Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Injectable HIV Medication Market Size by Type
  2. 9.1.1 Europe Injectable HIV Medication Revenue by Type (2021-2032)
  3. 9.1.2 Europe Injectable HIV Medication Sales by Type (2021-2032)
  4. 9.1.3 Europe Injectable HIV Medication Price by Type (2021-2032)
  5. 9.2 Europe Injectable HIV Medication Market Size by Application
  6. 9.2.1 Europe Injectable HIV Medication Revenue by Application (2021-2032)
  7. 9.2.2 Europe Injectable HIV Medication Sales by Application (2021-2032)
  8. 9.2.3 Europe Injectable HIV Medication Price by Application (2021-2032)
  9. 9.3 Europe Injectable HIV Medication Market Size by Country
  10. 9.3.1 Europe Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Injectable HIV Medication Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Injectable HIV Medication Market Size by Type
  2. 10.1.1 China Injectable HIV Medication Revenue by Type (2021-2032)
  3. 10.1.2 China Injectable HIV Medication Sales by Type (2021-2032)
  4. 10.1.3 China Injectable HIV Medication Price by Type (2021-2032)
  5. 10.2 China Injectable HIV Medication Market Size by Application
  6. 10.2.1 China Injectable HIV Medication Revenue by Application (2021-2032)
  7. 10.2.2 China Injectable HIV Medication Sales by Application (2021-2032)
  8. 10.2.3 China Injectable HIV Medication Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Injectable HIV Medication Market Size by Type
  2. 11.1.1 Asia Injectable HIV Medication Revenue by Type (2021-2032)
  3. 11.1.2 Asia Injectable HIV Medication Sales by Type (2021-2032)
  4. 11.1.3 Asia Injectable HIV Medication Price by Type (2021-2032)
  5. 11.2 Asia Injectable HIV Medication Market Size by Application
  6. 11.2.1 Asia Injectable HIV Medication Revenue by Application (2021-2032)
  7. 11.2.2 Asia Injectable HIV Medication Sales by Application (2021-2032)
  8. 11.2.3 Asia Injectable HIV Medication Price by Application (2021-2032)
  9. 11.3 Asia Injectable HIV Medication Market Size by Country
  10. 11.3.1 Asia Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Injectable HIV Medication Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Injectable HIV Medication Market Size by Type
  2. 12.1.1 SAMEA Injectable HIV Medication Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Injectable HIV Medication Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Injectable HIV Medication Price by Type (2021-2032)
  5. 12.2 SAMEA Injectable HIV Medication Market Size by Application
  6. 12.2.1 SAMEA Injectable HIV Medication Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Injectable HIV Medication Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Injectable HIV Medication Price by Application (2021-2032)
  9. 12.3 SAMEA Injectable HIV Medication Market Size by Country
  10. 12.3.1 SAMEA Injectable HIV Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Injectable HIV Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Injectable HIV Medication Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Injectable HIV Medication Value Chain Analysis
  2. 13.1.1 Injectable HIV Medication Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Injectable HIV Medication Production Mode & Process
  6. 13.2 Injectable HIV Medication Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Injectable HIV Medication Distributors
  9. 13.2.3 Injectable HIV Medication Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst